Opko Health Inc (OPK)

[OPKOHEALTH2022]

I got the following reply from OPK investor relations after complaining



Did you listen to the conference call? The company discussed their outstanding results with their second consecutive quarter of profitability:

Revenues increased 87%
COVID-19 testing has expanded BRL’s client base in other areas of testing
Pfizer is expected to file the BLA for somatrogon this quarter
RAYALDEE was approved by several European countries with more pending and will be launched in Europe next year
RAYLADEE for treatment of COVID-19 is underway
Continued strong guidance for next quarter


Dr. Frost stated the following in response to the Sian press release: “Before I turn the call over to Steve, I'd like to emphasize that we are always considering the best strategies to maximize shareholder value. All of our directors and management and many of our employees are shareholders of OPKO. It goes without saying that our focus remains on increasing the value of our shares.”



Kind regards,



Yvonne